Physician profile
Eric K Diner
NPI 1659473940
$12,590.88
in general payments reported to CMS, 2019-2025
43 companies · $4,093 in 2025
The $4,093 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $945 · 2020: $918 · 2021: $790 · 2022: $1,009 · 2023: $4,169 · 2024: $668 · 2025: $4,093.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,300 · Education: $3,000 · Food and Beverage: $2,629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,300.00 |
| Education | $3,000.00 |
| Food and Beverage | $2,629.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,000.00 | 2023 | Davinci Xi |
| Gyrus Acmi, INC. | $1,800.00 | 2025 | |
| Verathon INC. | $1,500.00 | 2025 | Npd Clinical Study |
| Coloplast Corp | $1,412.56 | 2019-2024 | Speedicath |
| Astellas Pharma US INC | $818.76 | 2019-2025 | Xtandi, Myrbetriq |
| Abbvie INC. | $581.65 | 2019-2025 | Lupron Depot, Botox |
| Endo Pharmaceuticals INC. | $414.06 | 2020-2024 | Xiaflex, Aveed, Edex |
| Sumitomo Pharma America, INC. | $383.70 | 2023-2025 | Gemtesa, Orgovyx |
| Endo USA, INC. | $286.46 | 2024-2025 | Xiaflex, Aveed, Edex |
| Procept Biorobotics Corporation | $271.15 | 2023-2025 | Aquabeam Robotic System |
| Boston Scientific Corporation | $254.82 | 2019-2025 | Spaceoar Vue System - 10ml, Lithovue |
| Antares Pharma, INC. | $222.78 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Janssen Biotech, INC. | $212.49 | 2021-2025 | Erleada |
| Axonics, INC. | $202.39 | 2022-2023 | Axonics, Bulkamid |
| Pfizer INC. | $103.10 | 2019-2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Diner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.